Bridging the Gap: Enhancing HPV (Human Papillomavirus) Education to Combat Rising Cancer Rates
29.11.2024
Human papillomavirus (HPV) infections are sexually transmitted and contribute significantly to the spread of cancers in both men and women, including oropharyngeal and cervical cancers. The shortcomings of the current preventative strategies are becoming increasingly obvious, underscoring the need for new approaches, especially in the area of health education. Information accessibility, cultural appropriateness, proper management of information accuracy, and the spread of misinformation are emerging as critical focal points for improving the situation. This health policy research review evaluates contributing factors, such as HPV policies, health literacy levels, cultural barriers, healthcare provider-to-patient education, school health education programs, and current awareness campaigns. Based on these findings, the study highlights the most effective strategy for providing actionable information to improve public health: a community-based, multifaceted, but integrated approach to HPV education. To achieve this goal, healthcare provider recommendations are absolutely critical in influencing vaccine decisions. Furthermore, physical and online information materials must be designed at the appropriate reading level, with cultural considerations in mind, and screened to aid comprehension and prevent the spread of misconceptions, stigmas, and misinformation.
Visit websitePROTECT-EUROPE Academic Publication - How to overcome information and communication barriers in Human Papillomavirus vaccination?
30.08.2024
A SWOT analysis based on the opinions of European family doctors in contact with young people and their parents.
Visit websitePROTECT-EUROPE Academic Publication: Healthcare Professionals’ Perspectives on HPV Recommendations
02.07.2024
The objectives of this exploratory study are to identify which themes are most frequently raised during the recommendation of vaccination to minors based on the characteristics of the population (religion, region of origin, gender, level of education and language proficiency) and to collect strategies to improve communication with a diverse population.
Visit websiteHPV World: The Bourgogne-Franche-Comté HPV Consortium: a local network to increase HPV awareness and vaccine coverage
15.04.2024
Vaccination against HPV in France has been recommended since 2007 for girls and since 2019 for boys aged 11 to 14 years (with catch-up vaccination possible up to 19 years of age). At the end of 2022, coverage for the full HPV vaccination schedule in France was around 48% among girls aged 16 years, well below the goal of 80% stipulated in the French national cancer plan for the period 2021 to 2025. The introduction of an HPV vaccination program in schools was requested in February 2023 by the President of France, and launched by the Ministry of Health in October 2023. The program will introduce HPV vaccination for girls and boys at the age of 12-13 in French secondary schools, and is based on successful models implemented in several other European countries.
Visit websiteHPW World: the Newsletter on HPV
04.03.2024
PROTECT-EUROPE is officially collaborating with HPV World, the online newsletter completely dedicated to the human papillomavirus. The project is devoted to generating a summary of the results of complex research areas of clinical relevance in a reader-friendly manner, with ample dissemination in the professional networks and interactive features. The newsletter is widely available in open access and is distributed electronically. Interested readers can join by registering on the official website.
Visit websiteHPV World - Bridging Gaps in HPV Prevention: The HPV Prevention Policy Atlas as a Vital Communication Tool
04.03.2024
The HPV Prevention Policy Atlas provides invaluable insights into the state of HPV prevention across the European region: it evaluates countries' policies in primary prevention (vaccination), secondary prevention (screening), and online information dissemination; and serves as a crucial means of communication, calling for action where needed.
DownloadHPV World - Interview with K Canfell - Part II
16.01.2024
In the context of the WHO cervical cancer elimination campaign (90% vaccination, 70% HPV screening, 90% treatment), which are important proposals related to HPV vaccination: required levels of female vaccine coverage? Added value of including routine vaccination of boys? Predictions on the protection afforded by one-dose vaccination?
Visit websiteHPV World - Interview with K Canfell - Part I
16.01.2024
Simulation models are essential to understand the future impact of cancer control interventions, especially when primary data are limited or long-term follow-up is lacking. Models are still perceived by some as too speculative to inform clinical decisions, but there is emerging understanding of the important role of comprehensive models.
Visit websiteHPV World - Strengthening HPV Vaccination Coverage, Data Quality, and Communication in Europe with project PERCH
15.01.2024
Although highly preventable through HPV vaccination and screening, cervical cancer remains a significant public health concern in Europe. In 2020, according to data from the Global Cancer Observatory, it was the 9th most common female cancer in Europe, with approximately 58,169 new cases and 25,989 deaths. Although HPV vaccines have been available since 2006, both introduction and coverage still do not reach optimal levels. These disparities highlight the urgent need to address the prevention and management of cervical cancer in Europe. In an effort to address preventable cervical cancers and other HPV-related cancers and health-disparities, the European PartnERship to Contrast HPV (PERCH) was funded as a Joint Action project by the European Health and Digital Executive Agency (HaDEA) in November 2022.
Visit website
